Dublin, Sept. 19, 2023 (GLOBE NEWSWIRE) -- The "Global Thyroid Eye Disease Treatments Market by Drug (Corticosteroid, Monoclonal Antibody, Vitamin), Route of Administration (Oral, Topical), Treatment, Diagnosis, Distribution - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Forecast 2023-2030" report has been added to ResearchAndMarkets.com's offering.
The Global Thyroid Eye Disease Treatments Market has experienced significant growth, with a CAGR of 9.50%. In 2022, the market was estimated at USD 272.50 million, and it is projected to reach USD 563.40 million by 2030.
Market Segmentation & Coverage: The report delves into various aspects of the market, providing crucial insights into different segments:
Drug Segment: The market is segmented into Corticosteroid, Monoclonal Antibody, and Vitamin. Monoclonal Antibodies held the largest market share in 2022 at 57.81%, followed by Corticosteroid.
Route of Administration: This segment includes Oral and Topical routes, with Topical administration claiming the majority share at 46.48% in 2022.
Treatment Options: The market covers Medication, Radioactive Iodine Therapy, and Surgery, with Medication dominating at 49.04% in 2022.
Diagnosis Methods: Diagnostic avenues include Blood Test, Imaging Test, Orbital Ultrasound, Physical Exam, and Radioactive Iodine Uptake Test, with Physical Exam leading at 32.93% in 2022, followed by Blood Test.
Distribution Channels: The market is distributed across Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy, with Hospital Pharmacy leading at 63.99% in 2022, followed by Retail Pharmacy.
Regional Analysis: The market is divided into Americas, Asia-Pacific, and Europe, Middle East & Africa. Europe, Middle East & Africa commanded the largest market share at 37.57% in 2022.
Market Dynamics: The report highlights the key factors driving and hindering market growth:
Drivers:
- High Prevalence of Autoimmune Diseases such as Grave's Disease and Hashimoto's Thyroiditis
- Awareness Raising National Health Programs Coupled with Favorable Reimbursement Policies related to Thyroid Disease Treatment
- Increasing Iodine Disorder and Thyroid Tumors Screening
Restraints:
- Limited Accessibility, Affordability, and Unmeasured Side Effects
Opportunities:
- Improving Healthcare Infrastructure
- Increasing Number of Ophthalmologists
- Growing Early Diagnosis Rate Coupled with Developing Novel Therapy for the Thyroid Eye
Challenges:
- Limitation Associated with the Availability of any Definitive Thyroid Eye Treatment
Key Insights and Questions Answered:
The report provides valuable insights into the market, answering essential questions such as:
- What is the market size and forecast of the Global Thyroid Eye Disease Treatments Market?
- How has COVID-19 impacted the market during the forecast period?
- Which segments and areas offer the best investment opportunities?
- What are the current technology trends and regulatory frameworks?
- Who are the leading vendors in the Global Thyroid Eye Disease Treatments Market, and what are their strategies?
Key Attributes:
- No. of Pages: 185
- Forecast Period: 2023 - 2030
- Estimated Market Value (USD) in 2023: $298.07 Million
- Forecasted Market Value (USD) by 2030: $563.4 Million
- Compound Annual Growth Rate: 9.5%
- Regions Covered: Global
Companies Mentioned
- Abbott Laboratories Inc.
- AbbVie, Inc.
- Akron Inc.
- AMRI Global
- Bausch & Lomb Incorporated
- Bayer AG
- Eyevance Pharmaceuticals LLC
- F. Hoffmann-La Roche AG
- Fujifilm Holdings Corporation
- GlaxoSmithKline PLC
- Horizon Therapeutics PLC
- Immunovant, Inc.
- Kala Pharmaceuticals, Inc.
- Mabxience Research Sl
- Merck KGaA
- Pfizer Inc.
- RLC Labs
- Sanofi S.A.
- Teva Pharmaceutical Industries Ltd.
- Viatris
For more information about this report visit https://www.researchandmarkets.com/r/uke1r8
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
